Comparative Pharmacology
Head-to-head clinical analysis: PROMETH HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE W CODEINE PHOSPHATE versus QOLIANA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROMETH HYDROCHLORIDE PHENYLEPHRINE HYDROCHLORIDE W CODEINE PHOSPHATE versus QOLIANA.
PROMETH HYDROCHLORIDE,PHENYLEPHRINE HYDROCHLORIDE W/CODEINE PHOSPHATE vs QOLIANA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promethazine is a phenothiazine derivative that acts as a histamine H1 receptor antagonist, anticholinergic, and antiemetic; phenylephrine is an alpha-1 adrenergic receptor agonist causing vasoconstriction; codeine is an opioid agonist at mu-opioid receptors, producing analgesia and antitussive effects.
QOLIANA (elagolix) is a nonpeptide, orally active gonadotropin-releasing hormone (GnRH) receptor antagonist that competitively binds to GnRH receptors in the pituitary gland, thereby reducing the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). This leads to decreased ovarian production of estrogen and progesterone, resulting in a hypoestrogenic state.
Promethazine 6.25 mg/phenylephrine 5 mg/codeine 10 mg per 5 mL oral solution: 5 mL every 4 hours as needed; max 30 mL/day.
Initiate at 5 mg orally once daily, increase as tolerated to 10 mg once daily. Maximum dose 20 mg once daily.
None Documented
None Documented
Codeine: 2.5-3.5 hours (neonates: 4.5 hours); Promethazine: 9-16 hours (metabolites up to 24 hours); Phenylephrine: 2-3 hours (oral) or 30-60 minutes (IV).
Terminal elimination half-life is 12 hours (range 10–15 hours) in healthy adults; may extend to 18–24 hours in patients with moderate hepatic impairment (Child-Pugh B).
Codeine: renal (10-30% unchanged, 40-70% as codeine-6-glucuronide, 5-15% as morphine and norcodeine conjugates); Promethazine: renal (70-80% as metabolites); Phenylephrine: renal (80-90% unchanged and as sulfate conjugates).
Renal excretion of unchanged drug accounts for approximately 30% of elimination; biliary/fecal excretion accounts for 60% (including metabolites); 10% is metabolized with negligible pulmonary elimination.
Category D/X
Category C
Opioid Agonist
Opioid Agonist